Director – Corporate Finance

Immuneel Therapeutics Pvt. Ltd.; Bengaluru; On-site; INR 4,000,000 - 7,000,000; Full time

Job summary

Immuneel Therapeutics Private Limited is a cutting-edge biotech startup in India focusing on cell therapy and personalized immunotherapy. The Director – Corporate Finance leads budgeting, FP&A, investor relations, treasury, and grant finance, reporting to the CFO and coordinating with the board and external investors.

The role encompasses planning, analysis, and governance to secure funding, manage liquidity, and enable clinical and commercial programmes.

Qualifications

• CA/MBA/CFA with 10–15 years of finance experience
• Experience in FP&A, management / board reporting and investor relations
• Hands-on exposure to fundraising, treasury and Indian regulatory finance (FEMA / RBI) and grant-funded environment advantageous

Responsibilities

• Own annual budgeting, monthly forecasting / reforecasting and FP&A – variance analysis, scenario modelling and cash runway tracking across commercial, clinical and R&D.
• Prepare the monthly MIS and the management and board reporting pack, built on the trial balance handed over by Controllership.
• Own investor relations and investor reporting – periodic updates, data-room upkeep, and ad-hoc investor and board requests.
• Manage treasury and cash, and execute funding – including term-loan drawdowns and covenant tracking – and support on FEMA / RBI filings and capital structuring.
• Own grant financials and claims (BIRAC, PRIP) and provide finance support to licensing and corporate-development transactions.

Skills

Analytical

Strategic thinking

Initiative

Organized

Collaborative

Results-oriented

Education

CA / MBA (Finance) / CFA or equivalent

Tools

SAP

PowerBI

Job description

Immuneel Therapeutics Private Limited is a pioneering start-up company leading the charge in cell therapy and personalized immunotherapy for patients in India. For more details, please refer www.immuneel.com

We Pursue, with Purpose, to serve our Patients (3 Ps) by Connecting within, Collaborating globally and Creating (3 Cs) solutions. Our flexible, diverse, and vibrant team is bringing together best practices and innovations in the field of cell and gene therapy.

Working at Immuneel promises the excitement of an agile start-up on a critical mission. Proudly Indian in solutioning, yet global in outlook, we are keen to collaborate. We value diversity including in experience and perspectives. We value work-life balance and believe that having fun on the job is integral to achieving the right results. We pride ourselves on providing an open environment and our mission resonates with humanity everywhere. At Work, we are:

• Passionate in driving patient outcomes: We are passionately committed to doing the RIGHT thing to achieve the best outcomes for our patients through innovation, agility and performance orientation. We put the impact on the patient above all else.
• Responsible and accountable: We demonstrate ownership and accountability for our actions. We make timely and well-informed decisions, learning from our performance.
• Transparent, honest, and supportive in how we work together: We insist on integrity and respect for the individual. We demand excellence. Our performance management is focused on excellence through timely and constructive feed-forward.
• Inclusive and flexible: We are full of life and embrace all opportunities to collaborate and work together. We are excited about the collective knowledge and expertise that we share. “Being and thinking different” is valued.

Immuneel’s employees are integral to our quest to develop and deliver high quality engineered cell therapies in India. We believe that our culture provides an environment for employees to excel and find purpose. The strength of our team is every bit as important as our cutting-edge technology and we invest in clear compensation and comprehensive benefits for our employees. People for us, are not resources, but our capital.

1. Role Title:

Director – Corporate Finance

2. Department/Function:

Finance & Investor Relations

3. Reporting Structure:

• Reports to: Chief Financial Officer (CFO)
• Direct Reports: Individual contributor at present; may build out FP&A / reporting analysts over time

4. Role Summary:

The Director – Corporate Finance owns the strategic and capital side of the finance function – planning and analysis, management and board reporting, investor relations, treasury and funding, and grant and corporate-development finance. Reporting to the CFO and operating as a peer to the Director – Financial Controller, the role converts the company’s financial position into decision-ready insight for the CFO, board and investors, and secures the funding and liquidity that support Immuneel’s commercial (Qartemi) and clinical (CD19-ALL, BCMA) programmes.

5. Key Responsibilities:

• Own annual budgeting, monthly forecasting / reforecasting and FP&A – variance analysis, scenario modelling and cash-runway tracking across commercial, clinical and R&D.
• Prepare the monthly MIS and the management and board reporting pack, built on the trial balance handed over by Controllership.
• Own investor relations and investor reporting – periodic updates, data-room upkeep, and ad-hoc investor and board requests.
• Manage treasury and cash, and execute funding – including term-loan drawdowns and covenant tracking – and support the CFO on FEMA / RBI filings and capital structuring.
• Own grant financials and claims (BIRAC, PRIP) and provide finance support to licensing and corporate-development transactions and any other activity assigned time to time.

6. Primary Objectives:

• Timely, accurate, board-ready reporting – MIS and board pack delivered each month, fully reconciled to the trial balance.
• Reliable planning and liquidity – budget and forecast within agreed tolerance, with no surprise cash-runway or covenant misses.
• Investor and capital readiness – investor requests met within agreed SLAs; funding drawdowns and grant claims executed on schedule.
• FP&A, budgeting, forecasting and financial modelling; strong command of Ind AS, MIS and management reporting.
• Treasury, fundraising and debt management (term loans, covenants), with working knowledge of FEMA / RBI and Companies Act compliance.
• Investor reporting and grant / statutory finance (BIRAC / PRIP exposure preferred); advanced Excel and ERP (SAP / PowerBI ) proficiency.
• Soft Skills:
• Ethical – guided by core values to act with integrity and honesty; uses good judgement in maintaining confidentiality of financial information.
• Diplomatic – tactful across diverse people and situations; handles sensitive board, investor and regulatory information with discretion.
• Persuasive – convincing and impactful; wins support for financial recommendations with the CFO, board and investors.
• Collaborative – participative, win‑win orientation; works cleanly alongside Controllership at the shared close and reporting seams.
• Results‑oriented – focuses on outcomes and works with a sense of urgency; consistently meets reporting and filing deadlines.
• Organized – plans and monitors to priorities; manages multiple reporting, budgeting and funding cycles without slippage.
• Analytical – draws sound conclusions from data; analyses complex financial problems systematically before acting.
• Strategic Thinker – future‑oriented; links short‑term actions to long‑range capital, runway and funding plans.
• Initiative – proactive; anticipates needs, develops ideas and takes decisive action independently.
• Committed – persists through obstacles to reach objectives.

8. Qualifications:

• CA / MBA (Finance) / CFA or equivalent, with 10–15 years of progressive finance experience, including a senior corporate‑finance or FP&A leadership role.
• Proven experience in FP&A, management / board reporting and investor relations, ideally in biotech / pharma / life‑sciences or a similarly regulated, capital‑intensive sector.
• Hands‑on exposure to fundraising, treasury and Indian regulatory finance (FEMA / RBI, Companies Act); experience in a grant‑funded environment (BIRAC / PRIP) an advantage.

9. Working Conditions:

• Role Type: Full Time and Onsite
• Work Hours: General Shift
• Travel Requirements: Occasional – up to 10% (investor meetings, banking and regulatory interactions)